Search

Displaying results 1 - 10 of 6079 in total
  1. Drug

    Ertapenem

    go.drugbank.com/drugs/DB00303
    ApprovedInvestigational

    [L14339] It was first authorized for use in the US in November 2001 and in Europe in April 2002.

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Ertapenem AptaPharma 1 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Ertapenem Panpharma 1 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  2. Drug

    Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate

    go.drugbank.com/drugs/DB14106
    ApprovedInvestigational

    Tetrakis (2-methoxyisobutylisocyanide) copper (I) tetrafluoroborate is a component of Cardiolite, a technetium Tc99m-based imaging agent used for assessing myocardial perfusion.[L12744]

    Products: MIBITEC 1 mg Kit für ein radioaktives Arzneimittel, CardioTOP 1 mg Kit für ein radioaktives Arzneimittel
  3. Drug

    Caspofungin

    go.drugbank.com/drugs/DB00520
    ApprovedInvestigational

    Caspofungin (brand name Cancidas worldwide) is an antifungal drug and the first member of a new drug class called the echinocandins, as coined by Merck & Co., Inc. It is typically administered intravenously. It shows activity against...

    Categories: Antimycotics for Systemic Use, Antiinfectives for Systemic UseProducts: Nigufo 50 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Nigufo 70 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  4. Drug

    Bendamustine

    go.drugbank.com/drugs/DB06769
    ApprovedInvestigational

    Bendamustine is a nitrogen mustard drug which has been used in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL). Bendamustine is a bifunctional mechlorethamine derivative capable of formi...

    Products: Bendamustin Mylan 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Levact 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  5. Drug

    Trabectedin

    go.drugbank.com/drugs/DB05109
    ApprovedInvestigational

    It is approved for use in Europe, Russia and South Korea for the treatment of advanced soft tissue sarcoma. … On October 23, 2015, the FDA approved trabectedin, (as Yondelis), for the treatment of specific soft tissue sarcomas.

    Products: Trabectedin TEVA 0,25 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Trabectedin TEVA 1 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  6. Drug

    Pemetrexed

    go.drugbank.com/drugs/DB00642
    ApprovedInvestigational

    It is indicated for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative

    Products: Pemetrexed Actavis 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Pemetrexed Actavis 1000 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  7. Drug

    Anidulafungin

    go.drugbank.com/drugs/DB00362
    Approved

    Anidulafungin or Eraxis is an anti-fungal drug manufactured by Pfizer that gained approval by the Food and Drug Administration (FDA) in February 21, 2006; it was previously known as LY303366. There is preliminary evidence that it has a s...

    Categories: Antimycotics for Systemic Use, Antiinfectives for Systemic UseProducts: Anidulafungin Accord 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Anidulafungin Mylan 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  8. Drug

    Remifentanil

    go.drugbank.com/drugs/DB00899
    ApprovedInvestigational

    Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic.

    Products: Ultiva 1 mg Pulver für ein Konzentrat zur Herstellung einer Injektions-/Infusionslösung, Ultiva 2 mg Pulver für ein Konzentrat zur Herstellung einer Injektions-/Infusionslösung
  9. Drug

    Thiotepa

    go.drugbank.com/drugs/DB04572
    ApprovedInvestigational

    It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression. … N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years.

    Products: Thiotepa Fresenius Kabi 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Thiotepa Fresenius Kabi 15 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
  10. Drug

    Vancomycin

    go.drugbank.com/drugs/DB00512
    ApprovedInvestigational

    As of January 29 2018, CutisPharma's Firvanq is the only FDA approved vancomycin oral liquid treatment option available for the the treatment of _Clostridium difficile_ associated diarrhea and enterocolitis

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Vancomycin Pfizer 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Vancomycin Hikma 500 mg - Pulver für ein Konzentrat zur Herstellung einer Infusionslösung